IQV — IQVIA HOLDINGS INC.

—
NYSE · Health Care · Life Sciences Tools & Services · CIK 1478242 ·
Last close
$270.37
Market Cap
$44.50B
52W High
$277.40
52W Low
$154.50
ADV30
1,499,460
Next earnings
2026-11-03

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 4,368,000,000 1,435,000,000 569,000,000 256,000,000 29,881,000,000 1,909,000,000 23,580,000,000
Mar 2026 4,151,000,000 1,355,000,000 565,000,000 274,000,000 29,675,000,000 1,947,000,000 23,326,000,000
Dec 2025 4,364,000,000 1,436,000,000 651,000,000 514,000,000 29,944,000,000 1,980,000,000 23,314,000,000
Sep 2025 4,100,000,000 1,373,000,000 573,000,000 331,000,000 28,727,000,000 1,814,000,000 22,439,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$2,819,000,000
Investing CF
$-2,231,000,000
Financing CF
$-684,000,000
CapEx
$-635,000,000
Dividends Paid
—
Buybacks
$-1,162,000,000
EPS Diluted TTM
$8.06
As of
2026-08-02

Balance + Analyst (yfinance extras)

Retained Earnings
$7,955,000,000
Inventory
—
Receivables
$3,387,000,000
ST Investments
$171,000,000
EBIT TTM
$2,345,000,000
Pretax Income TTM
$1,574,000,000
Interest Exp TTM
$771,000,000
Analysts
18

Yahoo Snapshot (yfinance, live)

Total Revenue
$16,983,000,064
EBITDA
$3,048,000,000
Free Cash Flow
$2,149,750,016
Enterprise Value
$57,392,340,992
Total Cash
$2,080,000,000
Total Debt
$16,254,999,552
Shares Out
164,600,000
Trailing EPS
$8.04
Book Value
$37.49
ROE
22.8%
ROA
5.1%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 16,310,000,000 2,287,000,000 1,360,000,000 29,944,000,000 23,314,000,000 6,503,000,000 2,654,000,000
Dec 2024 15,405,000,000 2,269,000,000 1,373,000,000 26,899,000,000 20,832,000,000 6,067,000,000 2,716,000,000
Dec 2023 14,984,000,000 2,061,000,000 1,358,000,000 26,681,000,000 20,569,000,000 6,112,000,000 2,149,000,000
Dec 2022 14,410,000,000 1,827,000,000 1,091,000,000 25,337,000,000 19,572,000,000 5,765,000,000 2,260,000,000

TTM Snapshot

Revenues TTM
$14,503,000,000
NetIncome TTM
$1,210,000,000
OpCashFlow TTM
$0
Assets (Latest)
$26,899,000,000
Forward EPS
$14.46

Max Pain — expiry 2026-11-20

max pain strike: $250.00 · spot: $270.57 · call oi: 2,277 · put oi: 1,781
Expected Move to 2026-11-20: ±$34.75 (12.84%) — implied range $235.82 – $305.32 · ATM straddle on $270.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
IDXX IDEXX LABORATORIES INC /DE $40.91B $519.26 —
INCY INCYTE CORP $25.11B $123.89 —
MEDP Medpace Holdings, Inc. $17.27B $618.88 —
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. $14.11B $292.84 —
ICLR ICON PLC $13.30B $172.33 —

News headlines (Yahoo Finance, 1h cache)

IQVIA Holdings (IQV) Prices $2b Notes, Does The Stock Look Fairly Valued?
2026-09-19 23:08 · Yahoo
IQVIA (IQV) Stock Could Be Undervalued After Its 42% Run
2026-09-19 21:13 · Yahoo
A Strong Rebound Case of IQVIA Holdings (IQV)
2026-09-15 13:57 · Yahoo
IQVIA Holdings Stock: Is IQV Outperforming the Health Care Sector?
2026-09-10 13:56 · Yahoo
IQVIA Announces Offering of Senior Notes
2026-09-09 12:15 · Yahoo
1 Profitable Stock with Solid Fundamentals and 2 That Underwhelm
2026-09-04 15:02 · Yahoo
IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster
2026-09-03 20:15 · Yahoo
Q2 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment
2026-08-31 20:52 · Yahoo
How Strong Q2 Beat And Raised 2026 Guidance At IQVIA Holdings (IQV) Has Changed Its Investment Story
2026-08-28 08:21 · Yahoo
IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare
2026-08-27 20:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.